Smooth Drug Development April 2023 News Release

We are working on the following new projects:

• We have been awarded several bioequivalence studies by our long-term sponsor (INN: Tofisopam and Ezetimibe).
• We have been awarded several medical documentation development projects.

We are happy to reach the following milestones in our projects:

• The clinical part of the Lopinavir+Ritonavir study was completed.
• 638 subjects were enrolled in the Multivitamins in Pregnant and Childbearing Women Observational Programme. 
• 36 patients were randomised in the international phase III study of the original drug in patients with chronic myeloid leukaemia.
• 240 subjects were randomised and 29 sites were initiated in the adezmapimod + vimdemer study for surgical adhesions.
• 114 subjects were randomised in the Phase III study in post-COVID-19 anxiety.